Citadel Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,204,252
| Closed | -$42.1M | – | 7172 |
|
|
2024
Q1 | $42.1M | Buy |
1,204,252
+949,414
| +373% | +$33.2M | 0.01% | 562 |
|
|
2023
Q4 | $9.68M | Buy |
254,838
+12,028
| +5% | +$457K | ﹤0.01% | 1245 |
|
|
2023
Q3 | $4.46M | Buy |
242,810
+175,999
| +263% | +$3.23M | ﹤0.01% | 1718 |
|
|
2023
Q2 | $1.73M | Buy |
66,811
+47,232
| +241% | +$1.23M | ﹤0.01% | 2542 |
|
|
2023
Q1 | $369K | Sell |
19,579
-39,328
| -67% | -$742K | ﹤0.01% | 4129 |
|
|
2022
Q4 | $1.45M | Buy |
58,907
+4,893
| +9% | +$121K | ﹤0.01% | 2860 |
|
|
2022
Q3 | $969K | Buy |
54,014
+9,482
| +21% | +$170K | ﹤0.01% | 3449 |
|
|
2022
Q2 | $506K | Sell |
44,532
-96,933
| -69% | -$1.1M | ﹤0.01% | 4130 |
|
|
2022
Q1 | $3.15M | Buy |
141,465
+131,778
| +1,360% | +$2.94M | ﹤0.01% | 2501 |
|
|
2021
Q4 | $423K | Buy |
+9,687
| New | +$423K | ﹤0.01% | 4764 |
|